HUBS vs KALA · P/E 96, rev $1.79B vs $54.3M cap
HubSpot Inc (HUBS) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. KALA currently screens at market cap $54.3M.
Not investment advice. Open the HUBS and KALA stock pages for the full models.
Not investment advice.